Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Maveropepimut-s by IMV for Epithelial Ovarian Cancer: Likelihood of Approval
Maveropepimut-s is under clinical development by IMV and currently in Phase II for Epithelial Ovarian Cancer. According to GlobalData, Phase...
Maveropepimut-s by IMV for Fallopian Tube Cancer: Likelihood of Approval
Maveropepimut-s is under clinical development by IMV and currently in Phase II for Fallopian Tube Cancer. According to GlobalData, Phase...
Maveropepimut-s by IMV for Peritoneal Cancer: Likelihood of Approval
Maveropepimut-s is under clinical development by IMV and currently in Phase II for Peritoneal Cancer. According to GlobalData, Phase II...
Maveropepimut-s by IMV for Peritoneal Cancer: Likelihood of Approval
Maveropepimut-s is under clinical development by IMV and currently in Phase II for Peritoneal Cancer. According to GlobalData, Phase II...
Maveropepimut-s by IMV for Fallopian Tube Cancer: Likelihood of Approval
Maveropepimut-s is under clinical development by IMV and currently in Phase II for Fallopian Tube Cancer. According to GlobalData, Phase...